Valsts: Austrālija
Valoda: angļu
Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)
duloxetine hydrochloride, Quantity: 67.3 mg (Equivalent: duloxetine, Qty 60 mg)
Dr Reddys Laboratories Australia Pty Ltd
Duloxetine hydrochloride
Capsule, enteric
Excipient Ingredients: hypromellose phthalate; triethyl citrate; purified talc; sucrose; hypromellose; glycine; maize starch; titanium dioxide; indigo carmine aluminium lake; purified water; iron oxide yellow; Gelatin; acetic acid; silicon dioxide; sodium lauryl sulfate; citric acid; propylene glycol; butan-1-ol; isopropyl alcohol; Shellac; ethanol absolute; ammonia; potassium hydroxide
Oral
7's, 14's, 10's, 28's
(S4) Prescription Only Medicine
Indications,1. Treatment of major depressive disorder (MDD),2. Treatment of diabetic peripheral neuropathic pain (DPNP),3. Treatment of generalised anxiety disorder (GAD)
Visual Identification: Size '1' hard gelatin capsule with opaque blue coloured cap and opaque green body, imprinted 'RDY610' on cap and '60 mg' on body with white ink; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2014-06-19